| Kayla Unkrich, | |
|
360 Polk St, Greenwood, IN 46143-1623 | |
| (317) 888-1557 | |
| (317) 888-1571 |
| Full Name | Kayla Unkrich |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 360 Polk St, Greenwood, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205315041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22007317A (Indiana) | Primary |
| Provider Name | Permanente Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound "drill" to break up the clots from the inside out.
MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals, including personal pharmacogenetic treatments.
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kayla Unkrich, 360 Polk St, Greenwood, IN 46143-1623 Ph: (317) 888-1557 | Kayla Unkrich, 360 Polk St, Greenwood, IN 46143-1623 Ph: (317) 888-1557 |
News Archive
Engineering researchers have developed a new technique for eliminating particularly tough blood clots, using engineered nanodroplets and an ultrasound "drill" to break up the clots from the inside out.
MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals, including personal pharmacogenetic treatments.
In a study published in the Proceedings of the National Academy of Sciences (PNAS) on Aug. 6, an international team led by Igor Roninson, of the University of South Carolina and the Medical University of South Carolina, reported the development of a new class of drugs that may prove useful in the treatment of cancer and aging-associated disorders.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
› Verified 8 days ago
Christina M Dulhanty, MA, CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd, Suite A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Elizabeth Amos, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Carol A Bell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Kaylee Nicole Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 Library Park Dr Ste A, Greenwood, IN 46142 Phone: 317-881-9923 | |
Ms. Kaitlin Sims, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3000 S State Road 135 Ste 110, Greenwood, IN 46143 Phone: 317-497-6000 | |
Olivia O'dell, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2339 S State Road 135, Greenwood, IN 46143 Phone: 317-535-0422 | |
Sara Reddington, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1701 Library Blvd Ste C, Greenwood, IN 46142 Phone: 317-881-9923 |